Patent cliff causes negative outlook for global pharma | Healthcare Finance News

The outlook for the global pharmaceutical industry remains negative as any potential revenue over the next 12-18 months is likely to be offset by losses from the upcoming expirations of major patents - known as the patent cliff - according to a new industry report by Moody’s Investors Service.


Featured Review
Tag Cloud
No tags yet.